Personalized Education and Pain Response in Chronic Pancreatitis
Key facts
- Who runs it
- Asian Institute of Gastroenterology, India
- Where
- India1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 114 people, planned
- Started
- 1 Aug 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Personalised education
- Record updated
- 30 July 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Chronic pancreatitis of at least 3 years
- At least 3 episodes of pain in the past 3 months
- Age 18-60yrs
- Both genders
Who cannot take part
- Active substance use (alcohol, smoking, smokeless tobacco, Illicit drugs)
- Psychiatric illness at enrolment or during follow-up, and/or concomitant intake of antidepressants and neuromodulators
- Pancreatic cancer
- Other chronic diseases (including end organ damage related to diabetes)
- Acute pancreatitis episode at the time of enrolment
- Adverse life event in the family in the past 6 months
- Pregnancy and lactation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pain mechanisms in chronic pancreatitis (CP) are heterogeneous and includes nociception, pancreatic neuropathy and central neuropathy/neuroplasty. These mechanisms could occur simultaneously in variable proportions and could explain why several patients develop recurrence of pain even after being treated by all the currently available modalities, such as antioxidants, endoscopic therapies and surgery.
Read full original descriptionShow less
In the studies by the investigators over the past 2 years, they observed that persistent pain in these patients was associated with varying grades of depression and poor quality of life. This was accompanied by alteration in the metabolites in the brain (anterior cingulate cortex, prefrontal cortex, hippocampus, and basal ganglia) as evidenced in magnetic resonance spectroscopy (MRS) of the brain. These areas in the brain are responsible for pain modulation, long-term pain memory and emotional responses to pain.
When the investigators counselled these patients and explained their disease and possible outcomes based on their own clinical course, imaging and treatment response (personalized education/counselling), they reported significant improvement in depression, quality of life parameters and, interestingly, also in pain. Further, there were changes in the metabolite parameters in the brain on MRS after personalized counselling/education that was more similar to that of healthy controls.
This led to our hypothesis that better understanding of the disease and its outcomes by the patients could improve their coping capabilities and increase their pain thresholds. This could augment the pain responses of these patients to the other therapeutic modalities.
We will conduct this single blinded, placebo controlled, randomized controlled trial on patients with documented CP of over 3 years duration, who had at least 3 episodes of abdominal pain of over the past 3 months.
The 2 groups in the trial
- Personalised educationTreatment being tested
1. Greetings. 2. Recording of demographic, clinical (disease related), nutritional, laboratory, and treatment related data. 3. Administration of questionnaires. 4. Inquiring patient's perception of their disease. 5. Explaining the patient about their disease in general followed by specific aspects and possible outcomes in the context of their perception, clinical aspects, questionnaire, and imaging data. In addition, the general treatment plan will be explained. 6. Address all queries from the patient and care givers.
- Standard communicationNo study treatment, for comparison
1. Greetings. 2. Recording of demographic, clinical (disease related), nutritional, laboratory, imaging and treatment related data. 3. Administration of questionnaires. 4. Explaining the general treatment plan. 5. Address general treatment related queries from the patient and care givers.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Personalized Education on Pain Response in Patients With Chronic Pancreatitis (PEPCP)
- Criteria questions
- Built from NCT04654377, who can take part
- Record updated
- 30 July 2025